For the Inventor, By the Inventor

Enter assignee name

Horsham, PA, United States of America

Janssen Biotech, Inc.

Calculating rank

USPTO Granted Patents = 436

% Expired Patents = 16.3

CIPO Patents = 28

EPO Patents = 199

Trademarks = 7

Forward Citations = 1,973

Loading Chart...

Loading Chart...

674 inventors (with patents filed for the assignee):

Jinquan Luo (43 out of 52 patents)

Steven Jacobs (38 out of 42 patents)

Raymond W Sweet (38 out of 47 patents)

4. Sheng-Jiun Wu (32 out of 36 patents)

5. Alireza Rezania (31 out of 48 patents)

6. Alexey Teplyakov (27 out of 32 patents)

7. David M Knight (27 out of 101 patents)

8. Jill M Giles-Komar (27 out of 56 patents)

9. Bernard Scallon (25 out of 49 patents)

10. Mark Hilary Cunningham (25 out of 46 patents)

11. Rajkumar Ganesan (24 out of 31 patents)

12. David J Shealy (24 out of 41 patents)

13. Karyn O'Neil (24 out of 39 patents)

14. Michael Diem (21 out of 22 patents)

15. Sanjaya Singh (19 out of 71 patents)

Core Competencies:

Anti-CD38 Antibodies

CAR-T Therapies

Inflammatory Bowel Disease

Biologics

Anti-TNF Antibodies

EGFR Inhibitors

Combination Therapies

Fibronectin Domains

Chimeric Antigen Receptors

Immunotherapy

Cancer Treatment

Drug Delivery

436 patents: Sort by Forward Citations

1. 12775014 - Multiparameter materials, methods and systems for enhanced bioreactor manufacture (2026-10-27),

2. RE51085 - ANTI-BCMA ANTIBODIES AND USES THEREOF (2026-10-20),

3. 12767934 - VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES (2026-10-20),

4. 12747289 - MANUFACTURING METHODS FOR PRODUCING ANTI-IL12/IL23 ANTIBODY COMPOSITIONS (2026-09-29),

5. 12742018 - SUBCUTANEOUS FORMULATIONS OF DARATUMUMAB AND THEIR USES IN TREATING MULTIPLE MYELOMA (2026-09-22),

6. 12735501 - Subcutaneous Formulations of daratumumab and their uses in treating multiple myeloma (2026-09-15),

7. 12698337 - Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses (2026-08-04),

8. 12692513 - Prostate neoantigens and their uses (2026-07-28),

9. 12673995 - MATERIALS AND METHODS FOR MODULATING T CELL MEDIATED IMMUNITY (2026-07-07),

10. 12655207 - SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL-23 SPECIFIC ANTIBODY (2026-06-16),

11. 12637519 - Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses (2026-05-26),

12. 12636300 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2026-05-26),

13. D1126399 - Syringe accessory (2026-05-12),

14. 12599652 - Serum Albumin-Binding Fibronectin Type III Domains (2026-04-14),

15. 12595510 - METHODS AND COMPOSITIONS FOR PREDICTION OF RESPONSE TO A THERAPY OF AN INFLAMMATORY BOWEL DISEASE (2026-04-07),

Company Overview

Janssen Biotech, Inc., located in Horsham, PA, specializes in the development and manufacturing of biologics, focusing on innovative therapies for serious medical conditions. The company is recognized for its advancements in anti-CD38 antibodies and CAR-T therapies, addressing diseases such as inflammatory bowel disease. Additionally, Janssen's expertise extends to anti-TNF antibodies, EGFR inhibitors, and combination therapies, leveraging fibronectin domains to enhance therapeutic efficacy in various treatment landscapes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

436 Patents

#3 in Horsham, PA

#46 in Pennsylvania

#1,090 in US

#2,174 in the World

Horsham, PA, United States of America

Janssen Biotech, Inc.

Forward Citations = 1,973

674 inventors:

Jinquan Luo (43 out of 52 patents)

Steven Jacobs (38 out of 42 patents)

Raymond W Sweet (38 out of 47 patents)

4. Sheng-Jiun Wu (32 out of 36 patents)

5. Alireza Rezania (31 out of 48 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Janssen Biotech, Inc.. Retrieved from https://idiyas.com/company/janssen-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…